Biotech Values

[db7]

re: Arbutus, Moderna, govt & EASL->

Govt liability ..1498..:
https://law.justia.com/cases/federal/district-courts/delaware/dedce/1:2022cv00252/78146/64/

https://www.wsj.com/articles/a-moderna-patent-bailout-would-set-a-dangerous-precedent-cb0e11d1

https://ipwatchdog.com/2023/03/08/pharma-companies-u-s-government-spar-application-section-1498-patent-infringement-claims-modernas-covid-19-vaccine/id=157459/

EASL June 6-8th:
https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-present-imdusiran-data-easl-congress-2024

"
HBsAg = LLOQ (lower limit of quantification) with detectable anti-HBs was observed at end-of-treatment in 28% of subjects who received 4 or 6 doses of imdusiran plus 24 weeks of IFN
"